Literature DB >> 17588710

Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.

Marc Dhenain1, Nadine El Tannir El Tayara, Ting-Di Wu, Maryvonne Guégan, Andreas Volk, Carmen Quintana, Benoît Delatour.   

Abstract

Amyloid deposits are one of the hallmarks of Alzheimer's disease. Recent studies, in transgenic mice modeling Alzheimer's disease showed that, using in vivo, contrast agent-free, MRI, thalamic amyloid plaques are more easily detected than other plaques of the brain. Our study evaluated the characteristics of these thalamic plaques in a large population of APP/PS1, PS1 and C57BL/6 mice. Thalamic spots were detected in all mice but with different frequency and magnitude. Hence, the prevalence and size of the lesions were higher in APP/PS1 mice. However, even in APP/PS1 mice, thalamic spots did not occur in all the old animals. In APP/PS1 mice, spots detection was related to high iron and calcium load within amyloid plaques and thus reflects the ability of such plaque to capture large amounts of minerals. Interestingly, calcium and iron was also detected in extra-thalamic plaques but with a lower intensity. Hypointense lesions in the thalamus were not associated with the iron load in the tissue surrounding the plaques, nor with micro-hemorrhages, inflammation, or a neurodegenerative context.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588710     DOI: 10.1016/j.neurobiolaging.2007.05.018

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.

Authors:  T M Wengenack; D A Reyes; G L Curran; B J Borowski; J Lin; G M Preboske; S S Holasek; E J Gilles; R Chamberlain; M Marjanska; C R Jack; M Garwood; J F Poduslo
Journal:  Neuroimage       Date:  2010-08-20       Impact factor: 6.556

2.  Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.

Authors:  Ryan Chamberlain; Thomas M Wengenack; Joseph F Poduslo; Michael Garwood; Clifford R Jack
Journal:  Curr Med Imaging Rev       Date:  2011-02

3.  Models of neurodegenerative disease - Alzheimer's anatomical and amyloid plaque imaging.

Authors:  Alexandra Petiet; Benoit Delatour; Marc Dhenain
Journal:  Methods Mol Biol       Date:  2011

4.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30

6.  MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.

Authors:  Mark D Meadowcroft; James R Connor; Michael B Smith; Qing X Yang
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

7.  Cerebral vascular leak in a mouse model of amyloid neuropathology.

Authors:  Eric A Tanifum; Zbigniew A Starosolski; Stephanie W Fowler; Joanna L Jankowsky; Ananth V Annapragada
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

8.  Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer's disease.

Authors:  Nadine El Tannir El Tayara; Benoît Delatour; Andreas Volk; Marc Dhenain
Journal:  MAGMA       Date:  2010-02       Impact factor: 2.310

9.  Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Authors:  Linda Zhang; Raymond Chuen-Chung Chang; Leung-Wing Chu; Henry Ka-Fung Mak
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

10.  Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.

Authors:  Ryan Chamberlain; Denise Reyes; Geoffrey L Curran; Malgorzata Marjanska; Thomas M Wengenack; Joseph F Poduslo; Michael Garwood; Clifford R Jack
Journal:  Magn Reson Med       Date:  2009-05       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.